Search

Author/Creator Cámara, J

3. P-191Randomized phase II clinical trial to evaluate the efficacy of second-line FOLFIRI-panitumumab in patients with RAS wild-type metastatic colorectal cancer who have received FOLFOX-panitumumab in first-line (BEYOND). (2nd July 2019)

Authors:
Aparicio, J; Virgili, A; Capdevila, J; Muñoz Boza, F; Álvarez, R; Bosch, C; Cámara, J; Fernandez-Martos, C; Fernandez-Plana, J; Gallego, J; Gallego, R; Hernández-Yagüe, X; Macías Declara, I; Rodríguez-Salas, N; Vera, R; Taberner, M; Maurel, J
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 4
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. P-266Retrospective analysis of clinical factors associated with a greater benefit with Trifluridine and Tipiracil in metastasic colorectal cancer. (20th June 2018)

Authors:
Rodriguez-Salas, N; Segura, M Soriano; Jimenez-Gordo, A; Molina, R; Cámara, J; Alfonso, A Lopez; Martínez-Amores, B; Fernandez, A Pertejo; Reynoso, G; Poma, J Miranda
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 5
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. P-266Retrospective analysis of clinical factors associated with a greater benefit with Trifluridine and Tipiracil in metastasic colorectal cancer. (20th June 2018)

Authors:
Rodriguez-Salas, N; Segura, M Soriano; Jimenez-Gordo, A; Molina, R; Cámara, J; Alfonso, A Lopez; Martínez-Amores, B; Fernandez, A Pertejo; Reynoso, G; Poma, J Miranda
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 5
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗